Evidence map›Paper›PMID 21559445›Full record

ArticlePloS one2011

Differential control of Yersinia pestis biofilm formation in vitro and in the flea vector by two c-di-GMP diguanylate cyclases.

Yi-Cheng Sun, Alexandra Koumoutsi, Clayton Jarrett, Kevin Lawrence, Frank C Gherardini, Creg Darby, B Joseph Hinnebusch

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Emergence, global dispersal, and local adaptations ofApplied and environmental microbiology · 2026
    Review
  3. Molecular Tracing and Comparative Genomics Analysis ofPathogens (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Article
  6. Role of themBio · 2024
    Article
  7. Article
  8. Article
  9. CsrA-Mediated Translational Activation of theJournal of bacteriology · 2023
    Article
  10. Article
  11. A frameshift ineLife · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. The Rcs System inFrontiers in microbiology · 2021
    Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yi-Cheng SunLaboratory of Zoonotic Pathogens, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America. sunyc@ipbcams.ac.cn
Alexandra Koumoutsi
Clayton Jarrett
Kevin Lawrence
Frank C Gherardini
Creg Darby
B Joseph Hinnebusch
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · USUniversity of California, San Francisco · US

Funding

The Roles of Key Transcription Factors on the Pathogenesis of B. Burgdorferi, the Causative Agent of Lyme DiseaseZIAAI000905 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GHERARDINI, FRANK · 2009 to 2023
$12.4M
Transmission Of Yersinia Pestis By Fleas: Molecular MechanismsZIAAI000796 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HINNEBUSCH, B J · 2009 to 2023
$9.7M
Yersinia pestis biofilms on C. elegansR01AI057512 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DARBY, CREG · 2004 to 2008
$1.5M
Yersinia pestis biofilm regulationR56AI057512 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DARBY, CREG · 2010 to 2010
$348k
Intramural NIH HHSNIAID NIH HHS AI057512NIAID NIH HHS R01 AI057512NIAID NIH HHS R56 AI057512
6 · The paper itself

Abstract

Yersinia pestis forms a biofilm in the foregut of its flea vector that promotes transmission by flea bite. As in many bacteria, biofilm formation in Y. pestis is controlled by intracellular levels of the bacterial second messenger c-di-GMP. Two Y. pestis diguanylate cyclase (DGC) enzymes, encoded by hmsT and y3730, and one phosphodiesterase (PDE), encoded by hmsP, have been shown to control biofilm production in vitro via their opposing c-di-GMP synthesis and degradation activities, respectively. In this study, we provide further evidence that hmsT, hmsP, and y3730 are the only three genes involved in c-di-GMP metabolism in Y. pestis and evaluated the two DGCs for their comparative roles in biofilm formation in vitro and in the flea vector. As with HmsT, the DGC activity of Y3730 depended on a catalytic GGDEF domain, but the relative contribution of the two enzymes to the biofilm phenotype was influenced strongly by the environmental niche. Deletion of y3730 had a very minor effect on in vitro biofilm formation, but resulted in greatly reduced biofilm formation in the flea. In contrast, the predominant effect of hmsT was on in vitro biofilm formation. DGC activity was also required for the Hms-independent autoaggregation phenotype of Y. pestis, but was not required for virulence in a mouse model of bubonic plague. Our results confirm that only one PDE (HmsP) and two DGCs (HmsT and Y3730) control c-di-GMP levels in Y. pestis, indicate that hmsT and y3730 are regulated post-transcriptionally to differentially control biofilm formation in vitro and in the flea vector, and identify a second c-di-GMP-regulated phenotype in Y. pestis.

Indexed as

BiofilmsAnimalsBacterial ProteinsCyclic GMPDisease Models, AnimalEscherichia coli ProteinsMiceMutationPhenotypePhosphorus-Oxygen LyasesPlagueProtein Structure, TertiarySiphonapteraVirulenceYersinia pestisBacterial Proteinsbis(3',5')-cyclic diguanylic acidCyclic GMPdiguanylate cyclaseEscherichia coli ProteinsHMST protein, Yersinia pestisPhosphorus-Oxygen Lyases

Identifiers

PMID21559445
PMCPMC3084805
OpenAlexW2060591258

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.